Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...
Investor's Business Daily on MSN
AI stocks: Will self-improving models decide who wins superintelligence race?
Self-improving models are reshaping the AI race as OpenAI, Anthropic, Google and others pursue superintelligence.
News: DXC’s new Bengaluru centre reflects India’s expanding role in enterprise modernisation as AI, legacy systems and ...
Vitalik Buterin outlined an updated “Lean Ethereum” roadmap that aims to overhaul nearly every major part of the network over three to four years while minimizing disruption to existing applications.
Alongside this rapid progress, an equally ambitious effort has emerged to construct ethical frameworks for intelligent ...
Moon bases, living to 100 and (finally!) flying cars. What 2076 and our future will look like may be stranger than we expect.
The latest generation of AI models are such competent coders, engineers and (soon) scientists that many worry they may be ...
The rise of AI has brought an avalanche of new terms and slang. Here is a glossary with definitions of some of the most ...
Background Adult-onset Still’s disease (AOSD) is a systemic autoinflammatory disorder lacking a gold-standard diagnostic ...
Vitalik Buterin introduced the Lean Ethereum roadmap with major upgrades for security, privacy, and scalability. Developers support the plan but want faster progress. Meanwhile, Ethereum recorded a ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results